)
Drägerwerk (DRW3) investor relations material
Drägerwerk Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview
Operates globally in medical and safety technology, with 16,687 employees and €3.5 billion net sales in 2025.
Medical division leads in Europe for ventilation and neonatal care; safety division is top in gas detection and impairment check equipment.
Focuses on R&D with €338 million spent in 2025 and 1,900 employees in R&D.
Service and consumables business is a key sales focus, leveraging a large installed base and over 3,100 service technicians.
Strong presence in developed markets (79% of sales), with targeted growth in developing countries (21%).
Financial performance
Net sales grew to €3,482 million in 2025, with a 3.3% nominal increase and 5.3% growth net of currency effects.
EBIT margin improved to 6.7% in 2025, with EBIT at €233 million.
Cash flow from operating activities reached €238 million in 2025; net financial debt reduced to €123 million.
Equity ratio increased to 51.5% by end of 2025.
Dividend policy targets at least 30% payout of net profit if equity ratio is above 40%.
Segment and regional performance
Medical division net sales reached €1,996 million in 2025, with strongest growth in the Americas.
Safety division net sales were €1,486 million in 2025, with notable growth in EMEA and Germany.
APAC region saw a decline in both divisions, while Americas and EMEA showed positive trends.
- Strong Q1 with higher sales, improved margins, and robust outlook for 2026.DRW3
Q1 202630 Apr 2026 - Record 2025 sales, margin growth, and innovation drive a strong outlook and defense expansion.DRW3
German Select VII Conference15 Apr 2026 - Record sales, higher EBIT, and increased dividends marked robust growth in 2025.DRW3
Q4 202524 Mar 2026 - 2025 sales reached €3.5bn with rising profitability and a focus on innovation and sustainability.DRW3
Investor presentation24 Mar 2026 - EBIT and net profit rose despite lower sales, led by safety division growth and one-off gains.DRW3
Q2 20242 Feb 2026 - Safety division growth and one-off gains drive higher earnings despite medical segment decline.DRW3
Q3 202418 Jan 2026 - EBIT up 17% to EUR 194M, stable sales, 2025 outlook: 1%-5% growth, higher dividend.DRW3
Q4 20246 Jan 2026 - Order intake hit a five-year Q1 high, but earnings fell as medical margins declined.DRW3
Q1 202528 Nov 2025 - Order intake hit a five-year high, but EBIT fell; 2025 guidance confirmed.DRW3
Q2 202516 Nov 2025
Next Drägerwerk earnings date
Next Drägerwerk earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)